Chan Henry Lee

Insider Reports History

Location
55 Cambridge Parkway, Suite 700 W, Cambridge, MA
Signature
/s/ Qing Nian, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chan Henry Lee:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BeOne Medicines Ltd. SVP, General Counsel Ordinary Shares 223K $76M $340.70 Oct 8, 2025 Direct
BeOne Medicines Ltd. SVP, General Counsel American Depositary Shares 0 $0 $351.12 Oct 8, 2025 Direct
BeOne Medicines Ltd. SVP, General Counsel Share Option (Right to Buy) 127K Oct 8, 2025 Direct

Insider Reports Filed by Chan Henry Lee

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONC BeOne Medicines Ltd. Oct 8, 2025 10 -$1.72M 4 Oct 10, 2025 SVP, General Counsel
ONC BeOne Medicines Ltd. Sep 10, 2025 11 -$1.5M 4 Sep 12, 2025 SVP, General Counsel
ONC BeOne Medicines Ltd. Aug 13, 2025 7 -$1.84M 4 Aug 15, 2025 SVP, General Counsel
ONC BeOne Medicines Ltd. Jul 30, 2025 1 -$280K 4 Jul 31, 2025 SVP, General Counsel
ONC BeOne Medicines Ltd. Jun 16, 2025 1 -$112K 4 Jun 18, 2025 SVP, General Counsel
ONC BeOne Medicines Ltd. Jun 10, 2025 2 $0 4 Jun 12, 2025 SVP, General Counsel
ONC BeOne Medicines Ltd. Jun 6, 2025 2 -$179K 4 Jun 10, 2025 SVP, General Counsel
BGNE BeiGene, Ltd. Mar 5, 2025 1 $0 4 Mar 7, 2025 SVP, General Counsel
BGNE BeiGene, Ltd. Feb 27, 2025 1 -$331K 4 Mar 3, 2025 SVP, General Counsel
BGNE BeiGene, Ltd. Feb 21, 2025 3 -$310K 4 Feb 25, 2025 SVP, General Counsel
BGNE BeiGene, Ltd. Sep 30, 2024 1 -$285K 4 Oct 2, 2024 SVP, General Counsel
BGNE BeiGene, Ltd. Jul 30, 2024 1 -$134K 4 Aug 1, 2024 SVP, General Counsel
BGNE BeiGene, Ltd. Jun 17, 2024 3 -$70K 4 Jun 20, 2024 SVP, General Counsel
BGNE BeiGene, Ltd. Jun 5, 2024 2 $0 4 Jun 7, 2024 SVP, General Counsel
BGNE BeiGene, Ltd. Jul 31, 2023 1 -$171K 4 Aug 2, 2023 SVP, General Counsel
BGNE BeiGene, Ltd. Jun 15, 2023 2 $0 4 Jun 20, 2023 SVP, General Counsel
BGNE BeiGene, Ltd. Jun 15, 2023 0 $0 3 Jun 20, 2023 SVP, General Counsel